TCI Wealth Advisors’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-706
Closed -$10.6K 2035
2023
Q1
$10.6K Buy
706
+606
+606% +$9.21K ﹤0.01% 1056
2022
Q4
$1.18K Hold
100
﹤0.01% 2087
2022
Q3
$1K Hold
100
﹤0.01% 2165
2022
Q2
$0 Buy
+100
New +$624 ﹤0.01% 2508
2022
Q1
Sell
-250
Closed -$5K 2446
2021
Q4
$5K Buy
250
+50
+25% +$1.3K ﹤0.01% 1724
2021
Q3
$7K Sell
200
-119
-37% -$3.68K ﹤0.01% 1388
2021
Q2
$12K Hold
319
﹤0.01% 873
2021
Q1
$15K Buy
319
+19
+6% +$913 0.01% 669
2020
Q4
$16K Hold
300
0.01% 546
2020
Q3
$8K Hold
300
﹤0.01% 648
2020
Q2
$6K Sell
300
-100
-25% -$1.61K ﹤0.01% 704
2020
Q1
$4K Sell
400
-100
-20% -$1.26K ﹤0.01% 796
2019
Q4
$6K Sell
500
-200
-29% -$1.52K ﹤0.01% 824
2019
Q3
$4K Hold
700
﹤0.01% 894
2019
Q2
$6K Hold
700
﹤0.01% 738
2019
Q1
$6K Buy
700
+100
+17% +$540 ﹤0.01% 754
2018
Q4
$2K Buy
600
+300
+100% +$1.49K ﹤0.01% 1068
2018
Q3
$2K Buy
300
+200
+200% +$2.29K ﹤0.01% 1090
2018
Q2
$1K Buy
+100
New +$1.38K ﹤0.01% 1381
2018
Q1
Sell
-200
Closed -$2K 1435
2017
Q4
$2K Hold
200
﹤0.01% 1066
2017
Q3
$2K Buy
+200
New +$2.28K ﹤0.01% 995

Other funds holding TGTX

TCI Wealth Advisors's TGTX Position: Q2 2023 in Review

TCI Wealth Advisors sold out of TG Therapeutics (TGTX) in Q2 2023, closing a stake of 706 shares — an estimated $10.6K sold.

TCI Wealth Advisors first reported a position in TGTX in Q3 2017 and held it in 21 quarters. The position peaked at $16K in Q4 2020. 244 funds tracked by Wall St. Rank hold TGTX as of Q2 2023.

  • TCI Wealth Advisors reported no remaining TG Therapeutics position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 706 TG Therapeutics shares in Q2 2023, an estimated $10.6K.
  • TCI Wealth Advisors first reported a position in TG Therapeutics in Q3 2017 and held it in 21 quarters.
  • TCI Wealth Advisors's TG Therapeutics position peaked at $16K in Q4 2020.
  • 244 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.